Galangin attenuates doxorubicin‐induced cardiotoxicity via activating nuclear factor erythroid 2‐related factor 2/heme oxygenase 1 signaling pathway to suppress oxidative stress and inflammation
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7991 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Guangyao Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, General Hospital of Western Theater Command, Chengdu, China. Hauptthemen laut MEDLINE: Cardiotoxicity, Heme Oxygenase-1. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
Doxorubicin (DOX) has aroused contradiction between its potent anti‐tumor capacity and severe cardiotoxicity. Galangin (Gal) possesses antioxidant, anti‐inflammatory, and antiapoptotic activities. We aimed to explore the role and underlying mechanisms of Gal on DOX‐induced cardiotoxicity. Mice were intraperitoneally injected with DOX (3 mg/kg, every 2 days for 2 weeks) to generate cardiotoxicity model and Gal (15 mg/kg, 2 weeks) was co‐administered via gavage daily. Nuclear factor erythroid 2‐related factor 2 (Nrf2) specific inhibitor, ML385, was employed to explore the underlying mechanisms. Compared to DOX‐insulted mice, Gal effectively improved cardiac dysfunction and ameliorated myocardial damage. DOX‐induced increase of reactive oxygen species, malondialdehyde, and NADPH oxidase activity and downregulation of superoxide dismutase (SOD) activity were blunted by Gal. Gal also markedly blocked increase of IL‐1β, IL‐6, and TNF‐α in DOX‐insulted heart. Mechanistically, Gal reversed DOX‐induced downregulation of Nrf2, HO‐1, and promoted nuclear translocation of Nrf2. ML385 markedly blunted the cardioprotective effects of Gal, as well as inhibitive effects on oxidative stress and inflammation. Gal ameliorates DOX‐induced cardiotoxicity by suppressing oxidative stress and inflammation via activating Nrf2/HO‐1 signaling pathway. Gal may serve as a promising cardioprotective agent for DOX‐induced cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, General Hospital of Western Theater Command, Chengdu, China.
- College of Medicine, Southwest Jiaotong University, Chengdu, China.
- Department of Nephrology, General Hospital of Western Theater Command, Chengdu, China.
- Department of Medical Oncology, People's Hospital of Luotian County, Huanggang, China.
- Department of Burn and Plastic Surgery, General Hospital of Western Theater Command, Chengdu, China.
ORCID-Profile: Cong Lan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
- Sichuan Province Science and Technology Support Program
- Popularization and Application Program of Sichuan Health Commission
Zitieren
APA
Fang, G., Li, X., Yang, F., Huang, T., Qiu, C., Peng, K., Yang, Y., & Lan, C. (2023). Galangin attenuates doxorubicin‐induced cardiotoxicity via activating nuclear factor erythroid 2‐related factor 2/heme oxygenase 1 signaling pathway to suppress oxidative stress and inflammation. Phytotherapy Research. https://doi.org/10.1002/ptr.7991
Vancouver
Fang G, Li X, Yang F, Huang T, Qiu C, Peng K, et al. Galangin attenuates doxorubicin‐induced cardiotoxicity via activating nuclear factor erythroid 2‐related factor 2/heme oxygenase 1 signaling pathway to suppress oxidative stress and inflammation. Phytotherapy Research. 2023. doi:10.1002/ptr.7991
BibTeX
@article{Fang2023,
author = {Fang, Guangyao and Li, Xiuchuan and Yang, Fengyuan and Huang, Ting and Qiu, Chenming and Peng, Ke and Yang, Yongjian and Lan, Cong},
title = {Galangin attenuates doxorubicin‐induced cardiotoxicity via activating nuclear factor erythroid 2‐related factor 2/heme oxygenase 1 signaling pathway to suppress oxidative stress and inflammation},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7991}
}
EUVIMED